Canadian pharmacy buying guide: drug characteristics, uses and benefits, side effects and interactions, and links for further information about buying discount drugs online from Canada.

Lumigan Consumer Information

LUMIGAN

Generic Name: bimatoprost ophthalmic (bih MAH toe prost)

Brand Names: Lumigan

What is the most important information I should know about bimatoprost ophthalmic?

  • Bimatoprost ophthalmic may cause a change in the color of the eyes and/or the skin around the eyes. The amount of brown pigment in the eyes and skin around the eyes may increase during treatment with bimatoprost ophthalmic, and it is not known if color changes are reversible after treatment. These changes occur slowly and may not be noticeable for months or years. Bimatoprost ophthalmic may also cause an increase in the length, thickness, and number of eyelashes. These effects may occur only in the eye being treated.
  • Do not touch the dropper to any surface, including the eyes or hands. The dropper is sterile. If it becomes contaminated, it could cause an infection in the eye, possibly resulting in a loss of vision.

What is bimatoprost ophthalmic?

  • Bimatoprost ophthalmic reduces pressure in the eye by increasing the amount of fluid that drains from the eye.
  • Bimatoprost ophthalmic is used to treat certain types of glaucoma and high pressure in the eye(s).
  • Bimatoprost ophthalmic may also be used for purposes other than those listed in this medication guide.

What should I discuss with my health care provider before using bimatoprost ophthalmic?

  • Before using bimatoprost ophthalmic, tell your doctor if you have:
    • an eye infection or other eye problems;
    • angle closure, inflammatory, or neovascular glaucoma;
    • liver disease, or
    • kidney disease.
  • You may not be able to use bimatoprost ophthalmic, or you may require a dosage adjustment or special monitoring during treatment.
  • Bimatoprost ophthalmic is in the FDA pregnancy category C. This means that it is not known whether bimatoprost ophthalmic will harm an unborn baby. Do not use bimatoprost ophthalmic without first talking to your doctor if you are pregnant.
  • It is not known whether bimatoprost passes into breast milk. Do not use bimatoprost ophthalmic without first talking to your doctor if you are breast-feeding a baby.

How should I use bimatoprost ophthalmic?

  • Use bimatoprost ophthalmic eyedrops exactly as directed by your doctor. If you do not understand these instructions, ask your doctor, pharmacist, or nurse to explain them to you.
  • Bimatoprost ophthalmic is usually used once a day, one drop in the affected eye or eyes, in the evening. Do not use more of this medication than is prescribed, as more frequent administration may decrease the effects of the medication. Since bimatoprost ophthalmic is used regularly, try to make applying the drops a part of your nightly routine. Follow your doctor's instructions.
  • Wash your hands before and after using the eyedrops.
  • Bimatoprost ophthalmic contains a preservative (benzalkonium chloride), therefore contact lenses should not be worn when applying the medication. Contact lenses may be reinserted 15 minutes after application of the drops.
  • To apply the eyedrops:
    • Tilt the head back slightly and pull down on the lower eyelid. Position the dropper above the eye. Steady the hand holding the bottle by placing the thumb against your brow or the bridge of the nose. Look up and away from the dropper. Gently press or lightly tap the side of the bottle to allow only a single drop of medicine to fall into the pocket formed by the lower eyelid. Do not allow the dropper to touch the eye. Close the eye and apply gentle pressure to the inside corner of the eye for approximately 2 to 3 minutes. If you are using drops in both eyes, repeat this procedure in the other eye. If you are also using another eye medication, wait at least 5 minutes before applying the other medication.
  • Do not touch the dropper to any surface, including the eyes or hands. The dropper is sterile. If it becomes contaminated, it could cause an infection in the eye possibly resulting in a loss of vision.
  • Contact your doctor if you develop any other problems with your eye(s) including signs of eye infection or if you need to have eye surgery during treatment with bimatoprost ophthalmic.
  • Do not use any eyedrop that is discolored or has particles in it.
  • Once the bottle is opened, bimatoprost ophthalmic can be stored at room temperature between 59 and 77 degrees Fahrenheit (15 and 25 degrees Celsius). Keep the bottle properly capped, in its original container.

What happens if I miss a dose?

  • Apply the missed dose as soon as you remember. However, if it is almost time for the next regularly scheduled dose, skip the missed dose and apply the next one as directed. Do not use a double dose of this medication.

What happens if I overdose?

  • Contact a poison control left or another emergency medical left for advice.
  • Symptoms of a bimatoprost ophthalmic overdose have not been reported.

What should I avoid while using bimatoprost ophthalmic?

  • Do not touch the dropper to any surface, including the eyes or hands. The dropper is sterile. If it becomes contaminated, it could cause an infection in the eye possibly resulting in a loss of vision.
  • Bimatoprost ophthalmic contains a preservative (benzalkonium chloride), therefore contact lenses should not be worn when applying the medication. Contact lenses can be inserted 15 minutes after application of the drops.
  • Apply other eye medications at least 5 minutes before or after a dose of bimatoprost ophthalmic, to prevent an interaction.

What are the possible side effects of bimatoprost ophthalmic?

  • Call your doctor immediately if you notice signs of infection such as itching or redness of the eyes or eyelids or discharge from the eyes.
  • More commonly, eye redness, discomfort burning, stinging, itching, blurred or decreased vision, dry eye, tearing, eyelid irritation, or a feeling of something in the eye may occur. Continue to use bimatoprost ophthalmic and talk to your doctor about these side effects if they occur.
  • Bimatoprost ophthalmic may cause a change in the color of the eyes and/or the skin around the eyes. The amount of brown pigment in the eyes and skin around the eyes may increase during treatment with bimatoprost ophthalmic, and it is not known if color changes are reversible after treatment. These changes occur slowly and may not be noticeable for months or years. Bimatoprost ophthalmic may also cause an increase in the length, thickness, and number of eyelashes. These effects may occur only in the eye being treated.
  • Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.

What other drugs will affect bimatoprost ophthalmic?

  • Before using this medication, tell your doctor if you are using another eye medication. Apply other medications at least 5 minutes before or after a dose of bimatoprost ophthalmic to prevent an interaction.
  • Drugs other than those listed here may also interact with bimatoprost ophthalmic. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.

Where can I get more information?

  • Your pharmacist has additional information about bimatoprost ophthalmic written for health professionals that you may read.
  • Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Limitations of This Canadian Pharmacy Information

Efforts have been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information does not endorse drugs, diagnose patients or recommend therapy. This is an educational resource only intended to supplement but not to replace the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, please check with your doctor, nurse or local pharmacist. This site does not assume any responsibility for any aspect of healthcare administered with the aid of information provided here.

Full public license and copyright information is available separately from Cerner Multum, Inc.

Version: 2.02. Revision Date: 2/14/03.